Protocol implementation of Shared Decision Making in Dutch breast cancer care; a prospective process evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27250

Enrollment

150

Registered

2016-03-24

Start date

2016-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Shared decision making Implementation Decision aid Patient communication Borstkanker Gezamelijk beslissen Keuzehulpen Implementatie Patient communicatie

Interventions

The intervention consists of offering patients a personalized patient decision aid.

Eligibility

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed breast cancer, stage I or II who are eligible for breast conserving therapy or mastectomy

Exclusion criteria

Exclusion criteria: Not understanding the Dutch language

Design outcomes

Primary

Measure	Time frame
With respect to our hypotheses on frequency of registering indication for a patient decision aid in the Multidisciplinary Board, for handing out and actually logging in, and assuming that that we can include 150 patients in total (5 hospitals, 30 patients per hospital), we expect that: -in 120 patients the indication for the decision aid is registered in the Multidisciplinary tumor board, i.e. in 80%, with a 95% CI of 74-86%. -in 105 patients the personalized decision aid will be handed out, i.e. in 70% with a 95% CI of 63-77%. -90 patients will actually log in to the patient decision aid, i.e. 60% with a 95% CI of 53-67%.	—

Measure

Time frame

With respect to our hypotheses on frequency of registering indication for a patient decision aid in the Multidisciplinary Board, for handing out and actually logging in, and assuming that that we can include 150 patients in total (5 hospitals, 30 patients per hospital), we expect that: -in 120 patients the indication for the decision aid is registered in the Multidisciplinary tumor board, i.e. in 80%, with a 95% CI of 74-86%. -in 105 patients the personalized decision aid will be handed out, i.e. in 70% with a 95% CI of 63-77%. -90 patients will actually log in to the patient decision aid, i.e. 60% with a 95% CI of 53-67%.

—

Secondary

Measure	Time frame
Evaluation experiences professionals of applying the Shared Decision Making and the use of the decision aid	—

Contacts

Public ContactW. Savelberg

Postbus 616

wilma.savelberg@maastrichtuniversity.nl043-3882336

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)